BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31773340)

  • 21. Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
    Lv X; Zhao Y; Zhang L; Zhou S; Zhang B; Zhang Q; Jiang L; Li X; Wu H; Zhao L; Wei M; He M
    J Cell Biochem; 2020 Feb; 121(2):1842-1854. PubMed ID: 31633246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer.
    Jeong SH; Park M; Park SY; Park J; Kim TH; Lee YJ; Jung EJ; Ju YT; Jeong CY; Kim JY; Ko GH; Kim M; Nam KT; Goldenring JR
    Technol Cancer Res Treat; 2021; 20():15330338211019501. PubMed ID: 34060350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
    Ge Y; Wei F; Du G; Fei G; Li W; Li X; Chu J; Wei P
    BMC Cancer; 2021 Mar; 21(1):240. PubMed ID: 33678158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of a 25-gene assay in patients with gastric cancer after curative resection.
    Wang X; Liu Y; Niu Z; Fu R; Jia Y; Zhang L; Shao D; Du H; Hu Y; Xing X; Cheng X; Li L; Guo T; Li Z; Ji Q; Zhang L; Ji J
    Sci Rep; 2017 Aug; 7(1):7515. PubMed ID: 28790411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.
    Wang G; Yang L; Wang Y; Hu R; Zhang K; Guo T; Chen B; Jiang X; Cui R
    Front Immunol; 2022; 13():939836. PubMed ID: 35898512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
    Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
    Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer.
    Song L; Wang XY; He XF
    Med Sci Monit; 2019 Aug; 25():6313-6320. PubMed ID: 31422414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
    Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
    Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
    Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
    Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data.
    Li F; Li J; Yu J; Pan T; Yu B; Sang Q; Dai W; Hou J; Yan C; Zang M; Zhu Z; Su L; Li YY; Liu B
    EBioMedicine; 2021 Jul; 69():103436. PubMed ID: 34157484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
    Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
    J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.
    Cao B; Zhao Y; Zhang Z; Li H; Xing J; Guo S; Qiu X; Zhang S; Min L; Zhu S
    Int J Oncol; 2018 Nov; 53(5):1857-1868. PubMed ID: 30106137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer.
    Wang KW; Wang MD; Li ZX; Hu BS; Wu JJ; Yuan ZD; Wu XL; Yuan QF; Yuan FL
    Front Immunol; 2022; 13():992060. PubMed ID: 36311733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
    Du F; Feng W; Chen S; Wu S; Cao T; Yuan T; Tian D; Nie Y; Wu K; Fan D; Xia L
    Cancer Lett; 2019 Jun; 452():103-118. PubMed ID: 30922917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.
    Shiozaki A; Ariyoshi Y; Iitaka D; Kosuga T; Shimizu H; Kudou M; Konishi T; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Ichikawa D; Otsuji E
    Gastric Cancer; 2019 May; 22(3):473-485. PubMed ID: 30191346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
    Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
    Gastric Cancer; 2017 Jan; 20(1):164-174. PubMed ID: 26681196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
    Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.